CORONAVIRUS/Taiwan-developed rapid screening reagent put into trial production
04/23/2020 01:30 PM
Taipei, April 23 (CNA) A research team at Academia Sinica has developed a key reagent for a pioneering rapid screening test for the COVID-19 coronavirus disease and the technology has been transferred to seven companies, one or two of which will be chosen for possible mass production, James Liao (廖俊智), president of Taiwan's most prestigious research institution, said Thursday.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
More in CORONAVIRUS
- Taiwan COVID-19 News Briefs: May 26Taiwan on Thursday reported 81,907 new COVID-19 cases, down slightly from the day before, and 104 deaths from the disease, according to the Central Epidemic Command Center (CECC).05/26/2022 09:27 PM
- Two children under 5 die from COVID-19 complicationsTwo girls under the age of 5 were among the 104 deaths linked to COVID-19 reported Thursday, bringing the number of children under 10 who have passed away from the disease in ...05/26/2022 04:50 PM
- Taiwan reports 81,907 new COVID-19 cases, 104 deathsTaiwan recorded 81,907 new COVID-19 cases on Thursday -- 81,852 domestic infections and 55 imported -- and a single-day high of 104 deaths from the disease, according to the ...05/26/2022 03:15 PM
Latest
- Society
Taiwan COVID-19 News Briefs: May 26
05/26/2022 09:27 PM - Society
National Police Agency establishes stalking and harassment response teams
05/26/2022 09:15 PM - Business
Taiwan unveils NT$34.56 billion COVID-19 subsidy plan
05/26/2022 07:53 PM - Politics
Taiwan upgrades website to expedite passport applications
05/26/2022 07:33 PM - Business
Taiwan, Lithuania hold high-level economic talks
05/26/2022 07:12 PM